This discussion will determine the appropriate editorial guidance for acceptance of and content development of responses to questions in surveys and questionnaires. Initial topics include:
Content acceptance criteria:
Only assessment instruments that are in the public domain or with expressed permission will have their response values added.
IP-restricted assessment values may only be added upon permission of the publisher. It is the responsibility of the requester to secure that permiss
This discussion was completed at the Wellington meeting. It was decided that the LOINC part disjunctive concepts would not be added to the International release. Concepts that would have been dependent on these concepts would be modeled as primitives.
Methods to handle disjunction were deemed to not be the purview of the editorial advisory group and will be communicated to the Modeling AG for future resolution.
In revising a couple terms associated with lymphadenopathy it was noticed that 1. Lymphadenopathy (disorder) is primitive.
2. Lymphadenopathy is defined in most medical dictionaries as "enlargement" yet is not defined with an ASSOCIATED MORPHOLOGY = Enlargement.
Should we revise the modeling of lymphadenopathy and its subtypes to include enlargement, which would allow many concepts to become fully defined and improve the inferences amongst some of the existing content?
In relation to ideas for the April meeting I've done a review of the Content Tracker issues that are impacting SIRS requests being progressed. This review has shown that quite a number of these trackers actually have assignees and a number are the bigger projects e.g. Substances. There are a couple that have no-one assigned but they are impacted by other projects. There are a small number that could be progressed by a single Consultant through the normal process and these would need pre-work if brought to the Editorial Panel.
Given that the Pre coordination Roadmap pattern trackers that are impacting SIRS progressing were looked at. Excluding those already being worked on e.g the Laterality issue, there are several that have between 11 and 27 SIRS on hold and they are listed below.
JIRA Issue
SIRS impacted as of Feb 16
22
12
24
26
27
12
14
16
11
There are also some Content tracker items that have been identified as Editorial Issues that the group might like to consider reviewing and updating and/ or closing as required. In some cases the decision may have been made though not formally documented. These did not have SIRS related issues.
The desire for increased text definitions tied to concepts has raised the question as to whether URLs that point to definition resources or the definition itself should be allowed. Initial discussion with the Editorial AG members has lead to a variety of opinions. Further evaluation and discussion is desired
The current editorial guidance on the use of slashes in FSNs states: "The forward slash should not be used in FSNs. Exceptions: A forward slash may be used for representing units of measure, as required in the pharmaceutical products hierarchy, and in laboratory test results and units of measure hierarchies. They may also be used in the construct "and/or" in FSNs. There should be no space either before or after the slash."
We have received a request to represent types of thalassemia that hav
It would be reasonable to increase the length of the calls to 90 minutes if the AG members are amenable to spending even more time discussing these issues. I will put it on the agenda for the 28th.
Jim
Keith Campbell